ET
REGN icon

Equitable Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Equitable Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$430K Buy
556
+31
+6% +$23.7K 0.02% 351
2025
Q4 		$405K Hold
525
– – 0.02% 350
2025
Q3 		$295K Hold
525
– – 0.01% 389
2025
Q2 		$276K Hold
525
– – 0.01% 392
2025
Q1 		$333K Hold
525
– – 0.02% 386
2024
Q4 		$374K Hold
525
– – 0.02% 377
2024
Q3 		$552K Sell
525
-306
-37% -$341K 0.04% 295
2024
Q2 		$873K Buy
+831
New +$806K 0.06% 214
2022
Q4 		– Sell
-645
Closed -$445K – 415
2022
Q3 		$445K Hold
645
– – 0.04% 264
2022
Q2 		$381K Hold
645
– – 0.03% 292
2022
Q1 		$451K Hold
645
– – 0.03% 266
2021
Q4 		$408K Sell
645
-750
-54% -$461K 0.03% 284
2021
Q3 		$844K Sell
1,395
-106
-7% -$65.8K 0.05% 193
2021
Q2 		$838K Sell
1,501
-262
-15% -$133K 0.05% 199
2021
Q1 		$834K Sell
1,763
-8,589
-83% -$4.18M 0.06% 186
2020
Q4 		$5M Sell
10,352
-311
-3% -$168K 0.37% 75
2020
Q3 		$5.97M Sell
10,663
-353
-3% -$214K 0.51% 55
2020
Q2 		$6.87M Sell
11,016
-336
-3% -$191K 0.63% 48
2020
Q1 		$5.54M Buy
11,352
+513
+5% +$212K 0.61% 47
2019
Q4 		$4.07M Buy
10,839
+933
+9% +$314K 0.4% 69
2019
Q3 		$2.75M Buy
9,906
+441
+5% +$130K 0.29% 85
2019
Q2 		$2.96M Buy
9,465
+1,255
+15% +$418K 0.31% 85
2019
Q1 		$3.37M Sell
8,210
-120
-1% -$49.4K 0.39% 75
2018
Q4 		$3.11M Buy
8,330
+246
+3% +$90K 0.41% 72
2018
Q3 		$3.27M Sell
8,084
-111
-1% -$42.2K 0.38% 78
2018
Q2 		$2.83M Buy
+8,195
New +$2.56M 0.36% 85

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Equitable Trust's REGN Position: Q1 2026 in Review

Equitable Trust increased its Regeneron Pharmaceuticals (REGN) stake by 5.9% in Q1 2026, buying an estimated $23.7K and bringing the position to 556 shares worth $430K. The position accounts for 0.02% of the portfolio, ranked #351.

Equitable Trust first reported a position in REGN in Q2 2018 and has held it in 26 quarters since. The position peaked at $6.87M in Q2 2020. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Equitable Trust held 556 shares of Regeneron Pharmaceuticals worth $430K as of Q1 2026.
  • Equitable Trust bought 31 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $23.7K.
  • Regeneron Pharmaceuticals made up 0.02% of Equitable Trust's portfolio in Q1 2026, its #351 holding.
  • Equitable Trust first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 26 quarters since.
  • Equitable Trust's Regeneron Pharmaceuticals position peaked at $6.87M in Q2 2020.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.